Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FSXQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,077
Award facts
- Contract value 100% obligated
- $10,077.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 6, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $10,077.31 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, which is not set-aside, represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The medication will be delivered to the contractor's location in Conshohocken, Pennsylvania, with a completion date of January 7, 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. As a subsidiary of Cencora, Inc., the company operates under the DLA's comprehensive pharmaceutical supply vehicle, which enables delivery of a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military treatment facilities and other federal healthcare institutions globally. This delivery order exemplifies the company's role in fulfilling essential pharmaceutical requirements across multiple therapeutic domains for the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FSXQ4?
SPE2DR26FSXQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FSXQ4 worth?
The government has obligated $10,077 on SPE2DR26FSXQ4.
Is contract SPE2DR26FSXQ4 an order under another contract?
Yes. SPE2DR26FSXQ4 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSXQ4 competed?
The extent of competition for SPE2DR26FSXQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award